MitoQ for improving weight and appetite in cancer patients
Part of Cancer clinical trials.
This study tests whether MitoQ, a dietary supplement that helps cells produce energy, can improve weight loss and appetite in people with cancer. It may also help slow down the muscle loss that often comes with cancer, so you can feel stronger and have a better quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older at the time you join the study.
- You must be able to attend all study visits and follow the study plan.
- You must have a solid tumor cancer that has been confirmed (for liver cancer, a clinical diagnosis may be enough).
- You must have unintended weight loss of more than 5% in the last 6 months, or weight loss of 5% or less along with poor appetite or metabolic changes.
- Your liver, kidney, and other organ functions must be within acceptable ranges.
- You must not have certain serious conditions, such as unstable heart disease or active infections like HIV or hepatitis B/C.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (QLS2319) to see if it’s safe and can help people with cancer-related weight loss and muscle loss (cachexia). It’s for people whose daily activities aren’t severely limited by their cancer.
This trial tests whether taking the supplement MitoQ before standard surgery can help treat triple-negative breast cancer. You would take MitoQ for a short time between diagnosis and surgery to see if it slows tumor growth.
This study tests a new drug called DS010 to see if it can help people with cancer-related weight loss and muscle loss (cachexia). The goal is to improve appetite and strength, which may help you feel better during cancer treatment.
This study tests whether a drug already approved for other cancers can help patients with advanced lung, pancreatic, or colorectal cancer who are losing weight. The drug may help improve appetite and weight stability.
This trial tests whether a supplement called MitoQ can improve blood vessel health, walking speed, and thinking skills in older adults who are frail or have mild memory problems. It aims to see if MitoQ helps maintain independence and quality of life.
This study tests a special form of megestrol acetate (a medicine that can help with appetite and weight gain) in people with advanced digestive system cancers who are about to start or are already taking a type of targeted therapy called a TKI. The goal is to see if it helps with cancer-related weight loss and wasting (cachexia).
Hear when a new Cancer Cachexia (CC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.